home / stock / entbf / entbf quote
Last: | $0.0421 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.0421 |
High: | $0 |
Low: | $0 |
Volume: | 1 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0421 | $0 | $0.0421 | $0 | $0 | 1 | 07-16-2024 |
$0.0421 | $0.0421 | $0.0421 | $0.0421 | $0.0421 | 175 | 07-15-2024 |
$0.10352 | $0 | $0.10352 | $0 | $0 | 218 | 07-12-2024 |
$0.10352 | $0 | $0.10352 | $0 | $0 | 10 | 07-11-2024 |
$0.10352 | $0.10352 | $0.10352 | $0.10352 | $0.10352 | 100 | 07-10-2024 |
$0.144 | $0.144 | $0.144 | $0.144 | $0.144 | 300 | 07-09-2024 |
$0.11588 | $0 | $0.11588 | $0 | $0 | 10 | 07-08-2024 |
$0.11588 | $0 | $0.11588 | $0 | $0 | 2 | 07-05-2024 |
$0.1159 | $0.11572 | $0.11588 | $0.1159 | $0.0913 | 960 | 07-04-2024 |
$0.11588 | $0.11572 | $0.11588 | $0.11588 | $0.09132 | 960 | 07-03-2024 |
$0.08995 | $0.08995 | $0.08995 | $0.08995 | $0.08995 | 100 | 07-01-2024 |
$0.10914 | $0.1516 | $0.10914 | $0.1516 | $0.10914 | 764 | 06-28-2024 |
$0.12644 | $0 | $0.12644 | $0 | $0 | 50 | 06-26-2024 |
$0.12644 | $0.12644 | $0.12644 | $0.12644 | $0.12644 | 746 | 06-25-2024 |
$0.0511 | $0.0966 | $0.0511 | $0.12604 | $0.0511 | 20,269 | 06-21-2024 |
$0.08484 | $0.14675 | $0.08484 | $0.14675 | $0.06406 | 559 | 06-20-2024 |
$0.0225 | $0.0225 | $0.0225 | $0.0225 | $0.0225 | 400 | 06-19-2024 |
$0.0225 | $0.0225 | $0.0225 | $0.0225 | $0.0225 | 400 | 06-18-2024 |
$0.0225 | $0.0432 | $0.0225 | $0.0432 | $0.0225 | 200 | 06-17-2024 |
$0.13856 | $0.13856 | $0.13856 | $0.13856 | $0.13856 | 211 | 06-14-2024 |
News, Short Squeeze, Breakout and More Instantly...
Entheon Biomedical Corp Com Company Name:
ENTBF Stock Symbol:
OTCMKTS Market:
Entheon Biomedical Corp Com Website:
2024-03-27 17:08:02 ET Addiction is an issue that affects a significant number of people worldwide. While conventional treatments have existed for decades, they offer a very low rate of efficacy, often as low as 5%. For Timothy Ko , CEO of Entheon Biomedical , the problem ...
2024-03-27 17:08:02 ET Leading-edge addiction recovery solution Entheon Biomedical is pioneering a leading-edge addiction recovery solution that harnesses the therapeutic potential of patient-centric psychedelic medicine to remedy the underlying causes of Substance Use Disorde...
MIAMI, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”) , a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, today issued a letter to shareholders from its Chief Executive Officer, Ben Kaplan. Dear Fel...